Why the study?
Early recognition of AKI progression is critical for effective management, and the utility of the Furosemide Stress Test in guiding treatment in CRS type 1 requires illustration.
Does a periarticular triamcinolone injection improve early postoperative quadriceps strength recovery compared to intravenous hydrocortisone in patients undergoing primary total knee arthroplasty?
RCT (n=60)
Single-blind
1:1 using STATA with a block size of four
No
Does a periarticular triamcinolone injection improve early postoperative quadriceps strength recovery compared to intravenous hydrocortisone in patients undergoing primary total knee arthroplasty?
Mean Difference: 20.63 (95% CI 2.66–38.59)
Absolute Event Rate: -43.11% vs -63.74%
p-value: p=0.02
A single periarticular injection of triamcinolone acetonide is superior to intravenous hydrocortisone for preserving early quadriceps strength and mobility immediately after primary total knee arthroplasty.
Early recognition of the progression of Acute kidney injury (AKI) helps in the effective management of the disease. The Furosemide Stress Test (FST) is helpful in such situations in management. FST is a simple dynamic functional test that determines renal tubular functional integrity, offering early diagnosis and prognostication of AKI. We report the utility of FST in the management of AKI (KDIGO—Kidney Disease Improving Global Outcomes) stage 1 in an elderly diabetic woman with Cardiorenal Syndrome (CRS) type 1. FST showed a negative diuretic response; hence, the patient was initiated on continuous renal replacement therapy (CRRT), and before discharge, the patient had normal renal function with a urine output of more than 1500 milliliters per day. FST helped us in the timely initiation of CRRT in the management of CRS type 1 in this patient, leading to a gratifying outcome.
No takes yet. Share an insight, caveat, or question.
Murali et al. (2026) conducted an RCT in Advanced knee osteoarthritis (n=60). Periarticular triamcinolone acetonide vs. Intravenous hydrocortisone was evaluated on Peak isometric quadriceps strength (QS) recovery on postoperative day 3 (% change from baseline) (Mean difference 20.63 percentage points, 95% CI 2.66-38.59, p=0.02).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: